The nation of Zimbabwe has declined a substantial US health deal valued at 367 million US dollars (272 million pounds) spanning five years over Washington's request for confidential data.
This move became public following a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa felt the deal was "unbalanced".
A government representative later clarified that the United States was demanding access to genetic material for research and commercial purposes while was unwilling to guarantee the benefits from future treatments.
"We must now begin the difficult and regrettable process of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for continued talks to find a agreement agreeable to both sides so the nation's vital HIV treatment initiative can be sustained.
Broader Context
This rejection comes after a similar situation in Kenya, where a court halted a similar deal with the US following legal challenges were filed about the safety of citizens' health data.
Since resuming office recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had managed aid for the American government, but Trump argued its spending was "inefficient" and his government was pursuing government-to-government deals to enhance openness and accountability.
Based on statements, Sixteen African countries have so far agreed to similar health pacts, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Deal
The funds for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration could have provided immense advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy through US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"Zimbabwe was being asked to share its biological resources and data indefinitely, with no equivalent assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could result from that provided information," he stated.
"In essence, our nation would supply the raw materials for medical research with no assurance that the end products would be available to our people if a new disease outbreak emerge."
National Interest and Global Health
He also said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending systems previously set up via the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with future pandemics.
"This framework is designed to ensure that when a country contributes its information, the resulting advantages – including medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to develop them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome further discussions with our US partners on how subsequent co-operation could be structured in a manner that honours the sovereignty and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but urged that negotiations must proceed since much of the country's Aids initiatives depended on external financing.
"In cases where specific concerns exist, including those involving information security or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," the group added.
The halted deal underscores the complex debate between accepting vital foreign assistance and protecting national sovereignty in an increasingly interconnected world.